Urgent.ly (ULY) Tender Offer: Agero to Acquire All Shares at $5.50 Cash

The Deal

On March 13, 2026, Urgent.ly Inc. (ULY) announced it had entered into an Agreement and Plan of Merger with Agero, Inc., a Nevada-based private company that has operated in the roadside-assistance space for over 50 years under the Wolk family. Under the agreement, Agero's wholly owned subsidiary Medford Hawk, Inc. will launch a tender offer to buy every outstanding share of ULY common stock for $5.50 per share in cash.

After the tender offer closes, any shares not tendered will be converted into the right to receive the same $5.50 per share through a second-step merger. This is a clean, all-cash deal with no contingent value rights (CVRs) or mixed consideration to worry about.

At roughly 2.2 million shares outstanding, the total deal value comes to approximately $12.1 million, making this a micro-cap acquisition. Urgent.ly is a technology platform for roadside assistance, using machine learning and data-driven dispatch. Agero manages over 150 million vehicles and 13 million service events annually, so the strategic logic is straightforward: bolt on ULY's tech to Agero's scale.

Price and Spread

The offer price of $5.50 represents a 170.9% premium to ULY's closing price of $2.03 on March 13, 2026, the last trading day before the announcement. Shares moved quickly, jumping 161% in after-hours trading that same day.

With the stock currently trading around $5.38, the gross spread to the tender price is about $0.12 per share, or roughly 2.2%. That is a thin spread, which generally signals the market views this deal as very likely to close. For context, ULY's 52-week range spans $1.76 to $14.90, so the offer sits well below historical highs but far above recent lows.

Timeline

Conditions and Risks

The tender offer's closing hinges on several conditions. The most important is the minimum condition: at least a majority of ULY's outstanding shares must be tendered. With only 5.12% locked up through support agreements, the vast majority of shares still need to voluntarily tender. That said, with the stock trading just pennies below the offer price, there is little economic incentive to hold out.

Beyond the minimum condition, the deal is subject to customary closing conditions. The filings mention regulatory approvals, though for a transaction of this size, antitrust review is unlikely to be a meaningful hurdle.

The more practical risk here is liquidity. ULY has been delisted from Nasdaq as of March 18, 2026. The company expects its shares to migrate to OTC markets, likely starting on OTC Pink before potentially moving to the OTCQB Venture Market. OTC trading typically means wider bid-ask spreads, lower volume, and more difficulty entering or exiting a position. If you already hold shares, this does not change the economics of the tender offer itself, but it does mean selling in the open market before the tender could come at a worse price.

There is also the standard deal-break risk. The merger agreement includes an outside date of July 31, 2026. If for any reason the transaction is not completed by then, either party may be able to terminate the agreement. The filings reference potential termination fees, though the specific amounts have not yet been disclosed in the preliminary communications.

Credit Facility Amendments

Alongside the merger agreement, Urgent.ly amended its credit facilities to bridge the gap until closing. The MidCap revolving credit facility had its liquidity covenants lowered and its maturity extended through July 31, 2026 to align with the deal timeline. The second lien term loan (Alter Domus as agent) was extended to November 28, 2026, with a conditional waiver of interest and fees if the deal closes on schedule. These amendments suggest ULY needed financial breathing room, which underscores why the board likely found Agero's offer attractive despite the seemingly low absolute price.

What Shareholders Should Do Right Now

There is nothing to do yet. The tender offer has not formally commenced. All four SEC filings are SC 14D-9C preliminary communications, which are essentially public disclosures that a deal has been announced. The actual tender offer materials, including the Schedule TO (from Agero) and the formal Schedule 14D-9 recommendation statement (from ULY's board), have not been filed.

Once the Schedule TO is filed, the 20-business-day clock begins. At that point, shareholders will receive formal offer documents explaining exactly how to tender their shares and the precise expiration date. Until then, there is no mechanism to tender, and no action is required.

If you are considering buying shares to capture the $0.12 spread, weigh that potential gain against the OTC liquidity risk and the uncertain timeline before the tender formally launches. A 2.2% gross return only works if the deal closes promptly. If the tender offer period stretches or the deal encounters delays, the annualized return shrinks and your capital is tied up in an illiquid OTC stock.

SEC Filings

All filings to date are preliminary communications. You can review them on EDGAR or through Urgent.ly's investor relations page. The key filing to watch for is the Schedule TO from Agero, which will formally commence the tender offer and contain the full terms and conditions.

For background on how tender offers work, the SEC provides a helpful investor bulletin on tender offer mechanics.

This analysis is for informational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell securities. Always do your own research and consult a financial advisor before making investment decisions. Information is based on publicly available filings and may become outdated as new filings are made.